![Mark Schneyer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 2 M $ in data 31/07/2026
Mark C.
Schneyer is Chief Financial Officer & Executive Vice President at ACADIA Pharmaceuticals, Inc. since 2021.
Previously, Mr. Schneyer was Vice President-Business Development at Pfizer Inc. from 2019 to 2020.
Mr. Schneyer completed undergraduate studies at The Wharton School of the University of Pennsylvania in 1996.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 06/08/2026 | 67.828 ( 0,04% ) | 2 M $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Direttore Finanziario/CFO | 10/09/2021 |
| Società | Posizione | Fine |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01/05/2020 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
